Company Filing History:
Years Active: 2023
Title: Sumire Honda Malca: Innovator in Biotech
Introduction
Sumire Honda Malca is a prominent inventor based in Reinach, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the area of opioid production. Her innovative work has led to the development of a unique patent that addresses challenges in the synthesis of important chemical compounds.
Latest Patents
Sumire holds a patent titled "Demethylation of reticuline and derivatives thereof with fungal cytochrome P450." This invention relates to recombinant host cells that express one or more genes encoding a cytochrome P450 enzyme capable of N-demethylating and/or O-demethylating reticuline and/or its derivatives. The methods outlined in her patent involve cultivating these recombinant hosts in a culture medium under specific conditions to produce N-demethylated and/or O-demethylated reticuline and its derivatives. This innovation is particularly valuable as it provides access to naturally unavailable and chemically difficult-to-produce starting materials for opioids.
Career Highlights
Sumire is currently associated with River Stone Biotech LLC, where she continues to advance her research and development efforts. Her work is instrumental in bridging the gap between biotechnology and pharmaceutical applications, particularly in the synthesis of complex organic compounds.
Collaborations
Throughout her career, Sumire has collaborated with notable colleagues, including Markus Schwab and Philipp Friedrich Berninger. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Sumire Honda Malca is a trailblazer in the field of biotechnology, with her patent contributing significantly to the production of essential chemical compounds. Her work exemplifies the intersection of innovation and practical application in the pharmaceutical industry.